Investigator
Olivier Le Tonqueze
MINK THERAPEUTICS INC · funded by NIAID
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $613k
- First award
- May 9, 2025
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
On this record.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- MINK THERAPEUTICS INC40momentum
OncologyGrant-onlyListed · INKT
- MINK THERAPEUTICS INC24momentum
OncologyGrant-onlyListed · INKT
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R41
Developing allogeneic iNKT cell adoptive therapy to improve outcomes for HSCT indications
$307kMay 9, 2025NIAIDMINK THERAPEUTICS INCNIH RePORTER · 11185953 (opens the source filing in a new tab)
- R41
Developing allogeneic iNKT cell adoptive therapy to improve outcomes for HSCT indications
$307kMay 9, 2025NIAIDMINK THERAPEUTICS INCNIH RePORTER · 11333020 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources